disorders of the cervix Flashcards
what is a nabothian cyst?
Cystic structure that forms when columnar epithelium is covered by squamous epithelium
translucent/yellow
benign, asx., no excision required
characteristics of cervical polyps
may be d/t chronic inflammation of cervical canal
benign, usu. < 3cm
Polypectomy for symptomatic patients
what cells make up the 3 parts of the cervix?
Ectocervix = Stratified squamous epithelium
*Transformation zone =
Squamo-columnar junction and metaplastic squamous epithelium
Endocervical canal =
Single layer mucin-producing columnar cells (sample needs endocervical cells)
HPV pathophys
enters through microlacerations during intercourse
Transition zone/metaplastic tissue very susceptible to virus vs. squamous tissue
infects basal layer 1st
can be latent mo’s to yr’s
migrates away from BM toward the surface
Squamous cell carcinoma and adenocarcinoma assoc. w/ which type of HPV?
SCC = HPV 16
adeno = HPV 18
what are low risk types of HPV
6 and 11
Who typically has highest rates of HPV
women, adolescents/young adults 15-24y/o
75-80% sex active will acquire before age 50
RF’s for HPV infx
- Multiple sexual partners
Smoking, immunosuppression, early onset sex activity, h/o STI’s, long-term OCP use, Hx VIN and VAIN
Performing a pap smear
go into T. zone including endocervical canal and rotate 180 degrees.
Pap smears and HPV DNA testing
Patients who have received HPV vaccination require…
ongoing Pap smears based on age appropriate guidelines
primary screening tool for cervical CA?
PAP alone vs. co-testing vs. HPV
25-29 PAP q 3 yrs
never HPV testing until 25…ever!!
start at age 21y/o til 65
when is screening for cervical cancer initiated?
the age of 21 despite the age of sexual debut
screening does NOT reduce rate of cerv. CA prior to 21
nearly all cases of HPV are cleared w/in…
1-2 yrs w/out producing neoplastic change
Adolescent patient encounters should include:
Contraceptive Counseling STI screening HPV vaccination education/administration safe sex practices No Pap smear unless in high-risk population
screening for cervical CA women aged 21-29
Cytology performance alone q 3 years
Do not perform HPV DNA testing